At 5.0% CAGR, Asia Pacific Intermittent Catheters Market is Projected to be Worth US$ 854.68 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific intermittent catheters market was valued at US$ 578.56 million in 2023 and is expected to reach US$ 854.68 million by 2031, registering a CAGR of 5.0% from 2023 to 2031. Surging prevalence of urinary incontinence and adoption of single-use catheters are among the critical factors attributed to drive the Asia Pacific intermittent catheters market growth.

Single-use intermittent catheters have been linked with improved health outcomes, including a lower risk of urinary tract infections (UTIs), urethral trauma, and quality of life. The use of single-use catheters for intermittent catheterization reduces the risk of short and long-term problems. Single-use intermittent catheters are highly recommended for patients with recurring UTIs. Moreover, they are a preferred option in many patients due to the convenience of use. Modern single-use catheters are designed to be inserted with proper safety and sterility measures using applicators, or they may be offered with an extra protective coating. According to an article published by BMJ Open (a medical journal), the incidence of using catheters for intermittent catheterization varies in different regions, and the preference is frequently motivated by financial conditions. Further, there are no regulatory foundations or evidence-based outcomes available that recommend the reuse or multiple use of catheters for intermittent catheterization. Thus, the adoption of single-use intermittent catheters is on the rise due to the reduced possibility of infections, and better sterility and lubrication measures. For instance, Coloplast offers Self-Cath Male, straight tip, Self-Cath Pediatric, Self-Cath Female, and other single use catheters, Thus, the rising adoption of single-use intermittent catheters drives the growth of the intermittent catheters market.

On the contrary, complications associated with catheterization hampers the growth of Asia Pacific intermittent catheters market.

By product, the Asia Pacific intermittent catheters market is bifurcated into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held 62.5% share of Asia Pacific intermittent catheters market share in 2023, amassing US$ 361.33 million. It is projected to garner US$ 545.28 million by 2031 to register 5.3% CAGR during 2023–2031.

In terms of indication, the Asia Pacific intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson’s Disease (PD), multiple sclerosis, and others. The urinary incontinence segment held 52.6% share of Asia Pacific intermittent catheters market share in 2023, amassing US$ 304.30 million. It is projected to garner US$ 456.84 million by 2031 to register 5.2% CAGR during 2023–2031.

Based on category, the Asia Pacific intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held 71.9% share of Asia Pacific intermittent catheters market share in 2023, amassing US$ 415.72 million. It is projected to garner US$ 621.65 million by 2031 to register 5.2% CAGR during 2023–2031.

By system type, the Asia Pacific intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters segment held 65.4% share of Asia Pacific intermittent catheters market share in 2023, amassing US$ 378.56 million. It is projected to garner US$ 573.40 million by 2031 to register 5.3% CAGR during 2023–2031.

In terms of end user, the Asia Pacific intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held 45.2% share of Asia Pacific intermittent catheters market share in 2023, amassing US$ 261.44 million. It is projected to garner US$ 371.34 million by 2031 to register 4.5% CAGR during 2023–2031.

Based on country, the Asia Pacific intermittent catheters market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.4% share of Asia Pacific intermittent catheters market in 2023. It was assessed at US$ 158.40 million in 2023 and is likely to hit US$ 240.18 million by 2031, registering a CAGR of 5.3% during 2023–2031.

Key players operating in the Asia Pacific intermittent catheters market are Advin Health Care Pvt Ltd, B Braun SE, Boston Scientific Corp, Cardinal Health Inc, Coloplast Corp, Convatec Group Plc, Hollister Inc, Teleflex Inc, and Wellspect HealthCare, among others.

• In April, 2024: Wellspect HealthCare launched LoFric Origo Sleeve, a new line extension to its LoFric Origo catheter range. The new product is part of company’s LoFric Origo range. The product features a non-touch technique, including a thin cover that runs along the catheter tube. It forms a protective sleeve that allows for more hygienic handling.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com